Policy On Disclosure Of Information By Third Parties
On occasion Liminal BioSciences Inc. (“Liminal”) forwards general information of interest and relating to its various fields of activities, as well as the use of its proprietary products within the healthcare industry. This service is provided to our shareholders as a means to inform them on the landscape in which Liminal is evolving. From time to time, Liminal will provide information to third parties as part of interviews or due diligence, with such information that can be incorporated in articles or research reports. As part of its policy, Liminal does not post such articles or research reports as Liminal cannot guarantee the accuracy or reliability for the subsequent distribution of this information by third parties (see full disclosure on the Legal Disclaimer page).

 

  1. Where is Liminal BioSciences’ registered office?

Liminal BioSciences’ registered office is located at 231 Dundas Street, East Belleville, Ontario, K8N 1E2. We also have operations and employees based throughout Canada and the UK.

 

  1. Who are the members of Liminal BioSciences’ Board of Directors?

You can view the Corporation’s Board of Directors by visiting the Board of Directors page on the website.

 

  1. Who are the members of the Liminal BioSciences’ management team?

You can view the Corporation’s management team by visiting the Management page on the website.

 

  1. How do I contact Investor Relations with a question or request?

You can submit questions to the Liminal investor relations team by contacting investors@liminalbiosciences.com or by submitting a request via the Contact Us page.

 

  1. When is Liminal BioSciences’ fiscal year end?

The Corporation’s fiscal year end is December 31.

 

  1. When are Liminal BioSciences’ earnings reporting dates?
  • Year End / Annual Report 2021– by or on March 31, 2022
  • First Quarter Earnings – by or on May 16, 2022
  • Second Quarter Earnings – by or on August 15, 2022
  • Third Quarter Earnings – by or on November 15, 2022

 

  1. When and where is Liminal BioSciences’ annual meeting of shareholders?

The Annual General Meeting was held on Monday, June 6, 2022 and was a virtual meeting.

 

  1. How do I get copies of Liminal BioSciences’ financial documents?

These may be downloaded from Liminal BioSciences’ web site at https://liminalbiosciences.com/resources/financial-reports

 

  1. How many common shares are currently issued and outstanding on a fully diluted basis?

As of March 31, 2022, the Company had 31,042,560 issued and outstanding common shares.

Update available on the www.NASDAQ.com website.

 

  1. Does Liminal BioSciences Issue Dividends?

Not as of yet.

 

  1. Who is Liminal BioSciences’ transfer agent

Our transfer agent is Computershare. You can contact Computershare via their website at: www.computershare.com.

Written requests by regular mail can be made to:

 

US Investors:

Computershare Investor Services

P.O. Box 43078

Providence, RI 02940-3078 USA

 

Canadian Investors:

Computershare Investor Services

100 University Avenue, 8th Floor, North Tower

Toronto, Ontario M5J 2Y1 Canada

 

Telephone enquiries at 1-800-564-6253 (toll free in Canada and the USA) between the hours of 8:30 am and 8:00 pm Eastern Time or 514-982-7555 (international direct dial).

E-mail: web.queries@computershare.com

 

  1. Who are the Corporation’s auditors?

The Corporation’s auditors are currently PricewaterhouseCoopers.

 

  1. Where can I find Liminal BioSciences’ latest regulatory filings?

To view Liminal BioSciences Inc.’s filed regulatory documents, visit the Canadian Securities Administrators’ SEDAR® website www.sedar.com* or U.S. Securities and Exchange Commission website https://www.sec.gov/*

*These links will take you to an independent third party website site.

 

  1. Where can I find Liminal's insider trading reports?

To view all electronic insider trading reports, visit the Canadian Securities Administrators’ SEDI website www.sedi.ca *

*These links will take you to an independent third party website site.

 

  1. How do I contact Liminal BioSciences for Investor Information?

Email: investor@liminalbiosciences.com

For updates on our business, please refer to our reports filed with the SEC and Canadian Securities Administrators.

 

  1. On what exchanges are the Corporation's shares listed for trading and what is the ticker symbol?

NASDAQ

Symbol: LMNL

 

  1. What is the purpose of the Form 20-F filed with the SEC and posted on Edgar and SEDAR?

The Annual Information Form (AIF) on form 20-F is an SEC filing submitted to the US Securities and Exchange Commission used by certain foreign private issuers to provide information.

Copies of the 20-F can be found on SEDAR at www.sedar.com and on EDGAR at www.sec.gov as well as on the SEC Filings section of our investor relations website.